MIAMI, April, 24, 2024 /PRNewswire/ -- Getlabs , the nationwide leader in at-home diagnostics collection, has joined forces with Inocras , a leading AI-driven whole genome testing company that empowers patients with critical genetic insights for cancer and rare diseases.Getlabs' mission is to save lives by delivering outstanding healthcare to everyone. The company has redesigned the lab experience around patients, allowing them to book lab sample collections conveniently and comfortably from their homes, creating greater accessibility and convenience in their care process.Inocras provides whole genome sequencing tests, which deliver patients deep insights into their cancer and rare disease by providing comprehensive and detailed analyses of an individual's genetic composition. The company's innovative digital service platform offers patients a seamless end-to-end experience, allowing them to request a test order, book at-home sample collections with the help of the Getlabs partnership, and receive test results with genetic counseling support.By embedding Getlabs' at-home lab collection services within Inocras's intuitive end-to-end patient testing process, this partnership promises a unique and enhanced experience for patients, who will benefit from its convenience and efficiency."We are thrilled to embark on this partnership with Inocras," said Kyle Michelson, CEO of Getlabs. "Together, we are empowering patients to take control of their health journey by providing them with access to lab collection services without having to travel to or sit in a waiting room."Inocras Chief Strategy Officer, Rebecca Jang, remarks, "We are thrilled to launch our whole genome diagnostics products, CancerVision and RareVision. They will provide a more holistic view on patients' disease and health, presenting not only commonly known mutations but also ultra rare and complicated mutations. Patients can get cutting-edge diagnostics through our patient-centric digital service platform

Getlabs, the largest nationwide provider for at-home diagnostic collections, has partnered with Fountain TRT, a leading provider of testosterone replacement therapy (TRT) for men, to offer convenient at-home hormone testing and treatment.